Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Leqembi Iqlik (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai")  and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher...

FDA Approves Wayrilz (rilzabrutinib) for Immune Thrombocytopenia

Paris, August 29, 2025 – The US Food and Drug Administration (FDA) has approved Wayrilz (rilzabrutinib) for adults with persistent or chronic...

New Gel May Help Prevent Hair Loss During Chemotherapy, Early Research Finds

THURSDAY, Sept. 4, 2025 — A new shampoo-like gel developed by researchers at Michigan State University could help protect cancer patients from a...

Sense of Life Purpose Lowers Risk for Cognitive Impairment

A sense of purpose in life (PiL) is associated with a lower risk for and later onset of cognitive impairment, according to a study published online in...

Risk for Second Cancer Low for Women Treated for Early, Invasive Breast Cancer

The risk for second primary cancers is higher for breast cancer survivors than for women in the general population; however, the risk remains low and is...

Paternal Prepubertal Passive Smoke Exposure Impacts Offspring Lung Function

Paternal passive smoke exposure before completing puberty may intergenerationally impair lung function in future generations, according to a study published...

Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation

Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control, but also faster progression to severe...

Florida Plans to End All Vaccine Mandates

THURSDAY, Sept. 4, 2025 — Florida may soon become the first state in the U.S. to eliminate all vaccine mandates, a major shift in health policy that...

Advanced Prostate Cancer Cases Rising as Fewer Men Are Screened, New Report Says

THURSDAY, Sept. 4, 2025 — Prostate cancer rates are climbing in the U.S. with more men being diagnosed at later stages when the disease is harder...

Life Expectancy Is Plateauing, Won't Reach 100, Researchers Say

THURSDAY, Sept. 4, 2025 — Bad news for folks hoping to become a centenarian: Average life expectancy isn’t expected to exceed 100 years anytime soon,...

Monthly News Roundup - August 2025

Wegovy Granted Accelerated Approval as First GLP-1 Treatment for the Treatment of MASH Novo Nordisk’s Wegovy (semaglutide) has received US Food...

Baxdrostat Demonstrated Statistically Significant and Clinically Meaningful Reduction in Systolic Blood Pressure in Patients with Hard-to-Control Hypertension in the BaxHTN Phase III Trial

Positive full results from the ​BaxHTN Phase III trial showed ​baxdrostat demonstrated a statistically significant and clinically meaningful reduction...

Common Pain Meds, Acetaminophen and Ibuprofen, Could Be Contributing To Antibiotic Resistance

FRIDAY, Aug. 29, 2025 — Common over-the counter painkillers might be quietly fueling antibiotic resistance, a new study warns. Ibuprofen and acetaminophen...

Read more news...

Recently Added

Recently added consumer and prescribing information: Nuvaxovid, mNEXSPIKE, Cyklx, Papzimeos, Brinsupri, Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Wayrilz Wayrilz (rilzabrutinib) is a kinase inhibitor indicated for the treatment of adult patients with persistent or chronic immune...
  • Dawnzera Dawnzera (donidalorsen) is a prekallikrein-directed antisense oligonucleotide indicated for prophylaxis to prevent attacks of hereditary...
  • Tonmya Tonmya (cyclobenzaprine hydrochloride) is a sublingual formulation of cyclobenzaprine hydrochloride indicated for the treatment of...

More FDA approvals